Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@hannibalspeaks Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1937207568218345472.png) @hannibalspeaks Specialsituationz

Specialsituationz posts on X about $nktr, upside, 2x, $vtyx the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1937207568218345472/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1937207568218345472/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX +158%

### Mentions: X [#](/creator/twitter::1937207568218345472/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1937207568218345472/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX +204%

### Followers: XXX [#](/creator/twitter::1937207568218345472/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1937207568218345472/c:line/m:followers.svg)

- X Week XXX +7.70%
- X Month XXX +131%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1937207568218345472/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1937207568218345472/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1937207568218345472/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXXX% [countries](/list/countries)  XXXX%

**Social topic influence**
[$nktr](/topic/$nktr) #29, [upside](/topic/upside) 4.76%, [2x](/topic/2x) 4.76%, [$vtyx](/topic/$vtyx) 4.76%, [$tern](/topic/$tern) 4.76%, [$lly](/topic/$lly) 4.76%, [rep](/topic/rep) 4.76%, [$ovid](/topic/$ovid) 4.76%, [$crvs](/topic/$crvs) 4.76%, [france](/topic/france) XXXX%

**Top accounts mentioned or mentioned by**
[@logicalthesis](/creator/undefined) [@jul05310473john](/creator/undefined) [@popescuf](/creator/undefined) [@seedy19tron](/creator/undefined) [@houndcl](/creator/undefined) [@amaymd](/creator/undefined) [@biotenic](/creator/undefined) [@taintslapp12283](/creator/undefined) [@smiuffy](/creator/undefined) [@investorclimber](/creator/undefined) [@sanctuarybio](/creator/undefined) [@bananaoncology](/creator/undefined) [@tradingsssss](/creator/undefined) [@banana_oncology](/creator/undefined) [@thecellengineer](/creator/undefined) [@justiceforb_md](/creator/undefined) [@lindendoss](/creator/undefined) [@iotaresearch](/creator/undefined) [@pedro3236143411](/creator/undefined) [@plainyogurt21](/creator/undefined)

**Top assets mentioned**
[Eli Lilly and Company (LLY)](/topic/$lly)
### Top Social Posts [#](/creator/twitter::1937207568218345472/posts)
---
Top posts by engagements in the last XX hours

"@popescuf @LogicalThesis At this price there is no downside. M&A Comps for ph2 AD agents (Rocatinlimab) support current price without valuing multiple likely catalysts. It's safe to be irresponsibly long. Best was to buy pretrial or shortly after but there's definitively high prob 2x upside in XX mths"  
[X Link](https://x.com/hannibalspeaks/status/1979660003658301515) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-18T21:24Z XXX followers, XX engagements


"I'm tired of endless $NKTR chatter; nobody wants to discuss $VTYX or $TERN"  
[X Link](https://x.com/hannibalspeaks/status/1979675265841422827) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-18T22:25Z XXX followers, 1353 engagements


"@LogicalThesis They will need 700-1000 patients over two ph3 trials. FDA may neccistate enrollment of some biologic experienced patients. Going to be expensive they have a dirty rep after $LLY and failed trial mitigating again partnership. May result in dilutive financing"  
[X Link](https://x.com/hannibalspeaks/status/1979950973754696029) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-19T16:41Z XXX followers, XXX engagements


"@LogicalThesis To clarify Nektar has blown up X x billion dollar big pharma partnerships. With LLY and Merck. These were well publiced and if there is a big pharma black list they're on it. Current litigation is a further bad look - fairly or unfairly"  
[X Link](https://x.com/hannibalspeaks/status/1979952808523682065) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-19T16:48Z XXX followers, XXX engagements


"@smiuffy @houndcl @Investorclimber If they screwed retail once how do u know they wont do it on the next readout $ovid @seedy19tron"  
[X Link](https://x.com/hannibalspeaks/status/1974168365452407112) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-03T17:43Z XXX followers, XXX engagements


"Expecting a partial data release from $CRVS with some of cohort X that will be better than a follow-up release with the full data"  
[X Link](https://x.com/hannibalspeaks/status/1976021065534198054) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-08T20:25Z XXX followers, XXX engagements


"That's X million for a mab destined to fail and that had no preclinical data until biotwitter made a fuss. Meanwhile the guy in France who helped create a first in medicine earned a 10th of the US salary"  
[X Link](https://x.com/hannibalspeaks/status/1977486564763881906) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-12T21:28Z XXX followers, XXX engagements


"Those are earnings independent of outcome. No wonder you have $VYNE and so may zombie companies who should return capital"  
[X Link](https://x.com/hannibalspeaks/status/1977488718807367760) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-12T21:37Z XXX followers, XXX engagements


"Let's make it easy. Market thinks APGE/KYMR will win bing chunks of AtD market and they are priced accordingly. Relative fair value for $NKTR is at equivalent EV valuation. Absolute fair value $98/sh. NKTR is Bud Crawford the others Canelo"  
[X Link](https://x.com/hannibalspeaks/status/1979607366523076719) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-18T17:55Z XXX followers, XXX engagements


"@Banana_Oncology What's the simplest explanation"  
[X Link](https://x.com/hannibalspeaks/status/1979959754504999016) [@hannibalspeaks](/creator/x/hannibalspeaks) 2025-10-19T17:16Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@hannibalspeaks Avatar @hannibalspeaks Specialsituationz

Specialsituationz posts on X about $nktr, upside, 2x, $vtyx the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXX -XX%
  • X Month XXXXXX +158%

Mentions: X #

Mentions Line Chart

  • X Week XX -XX%
  • X Month XX +204%

Followers: XXX #

Followers Line Chart

  • X Week XXX +7.70%
  • X Month XXX +131%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXXX% finance XXXX% countries XXXX%

Social topic influence $nktr #29, upside 4.76%, 2x 4.76%, $vtyx 4.76%, $tern 4.76%, $lly 4.76%, rep 4.76%, $ovid 4.76%, $crvs 4.76%, france XXXX%

Top accounts mentioned or mentioned by @logicalthesis @jul05310473john @popescuf @seedy19tron @houndcl @amaymd @biotenic @taintslapp12283 @smiuffy @investorclimber @sanctuarybio @bananaoncology @tradingsssss @banana_oncology @thecellengineer @justiceforb_md @lindendoss @iotaresearch @pedro3236143411 @plainyogurt21

Top assets mentioned Eli Lilly and Company (LLY)

Top Social Posts #


Top posts by engagements in the last XX hours

"@popescuf @LogicalThesis At this price there is no downside. M&A Comps for ph2 AD agents (Rocatinlimab) support current price without valuing multiple likely catalysts. It's safe to be irresponsibly long. Best was to buy pretrial or shortly after but there's definitively high prob 2x upside in XX mths"
X Link @hannibalspeaks 2025-10-18T21:24Z XXX followers, XX engagements

"I'm tired of endless $NKTR chatter; nobody wants to discuss $VTYX or $TERN"
X Link @hannibalspeaks 2025-10-18T22:25Z XXX followers, 1353 engagements

"@LogicalThesis They will need 700-1000 patients over two ph3 trials. FDA may neccistate enrollment of some biologic experienced patients. Going to be expensive they have a dirty rep after $LLY and failed trial mitigating again partnership. May result in dilutive financing"
X Link @hannibalspeaks 2025-10-19T16:41Z XXX followers, XXX engagements

"@LogicalThesis To clarify Nektar has blown up X x billion dollar big pharma partnerships. With LLY and Merck. These were well publiced and if there is a big pharma black list they're on it. Current litigation is a further bad look - fairly or unfairly"
X Link @hannibalspeaks 2025-10-19T16:48Z XXX followers, XXX engagements

"@smiuffy @houndcl @Investorclimber If they screwed retail once how do u know they wont do it on the next readout $ovid @seedy19tron"
X Link @hannibalspeaks 2025-10-03T17:43Z XXX followers, XXX engagements

"Expecting a partial data release from $CRVS with some of cohort X that will be better than a follow-up release with the full data"
X Link @hannibalspeaks 2025-10-08T20:25Z XXX followers, XXX engagements

"That's X million for a mab destined to fail and that had no preclinical data until biotwitter made a fuss. Meanwhile the guy in France who helped create a first in medicine earned a 10th of the US salary"
X Link @hannibalspeaks 2025-10-12T21:28Z XXX followers, XXX engagements

"Those are earnings independent of outcome. No wonder you have $VYNE and so may zombie companies who should return capital"
X Link @hannibalspeaks 2025-10-12T21:37Z XXX followers, XXX engagements

"Let's make it easy. Market thinks APGE/KYMR will win bing chunks of AtD market and they are priced accordingly. Relative fair value for $NKTR is at equivalent EV valuation. Absolute fair value $98/sh. NKTR is Bud Crawford the others Canelo"
X Link @hannibalspeaks 2025-10-18T17:55Z XXX followers, XXX engagements

"@Banana_Oncology What's the simplest explanation"
X Link @hannibalspeaks 2025-10-19T17:16Z XXX followers, XXX engagements

@hannibalspeaks
/creator/twitter::hannibalspeaks